Chai Discovery secures $70m to accelerate AI-driven protein design
Endpoints News - 06-Aug-2025Biotech startup’s valuation soars as it advances de novo protein generation with AI models.
Join the club for FREE to access the whole archive and other member benefits.
A biotechnology company specializing in molecular diagnostic tools
Chai Discovery is a company that provides tools and platforms for scientific research, focusing on technologies that streamline and automate laboratory workflows. It specializes in creating molecular diagnostic tools and laboratory instruments, with a focus on real-time PCR devices and related software for scientific research and diagnostics. Chai Discovery has introduced Chai-1, a multi-modal AI model designed for molecular structure prediction, achieving state-of-the-art performance in drug discovery tasks. Chai-1 excels at predicting proteins, small molecules, DNA, RNA, and more, surpassing benchmarks like AlphaFold. It's available for free through a web interface, including commercial use, and the code is open for non-commercial applications. The model can predict structures without MSAs and enhance drug discovery with lab data integration, reflecting the company’s mission to transform biology into engineering.
Visit website: https://www.chaidiscovery.com/
Details last updated 24-Sep-2024
Biotech startup’s valuation soars as it advances de novo protein generation with AI models.
An AI model set to transform drug discovery through cutting-edge molecular predictions